We are live on
!
Find out more
HW
Hancock Whitney Portfolio holdings
AUM
$5.75B
1-Year Est. Return
24.3%
This Fund
S&P 500
This Quarter
Est. Return
-13.35%
1 Year Est. Return
+24.3%
3 Year Est. Return
+81.4%
5 Year Est. Return
+108.63%
10 Year Est. Return
+431.68%
AUM
$2.5B
AUM Growth
-$437M
(-15%)
Cap. Flow
-$1.27M
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
27.24%
Holding
698
New
16
Increased
159
Reduced
431
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$26.6M |
| 2 |
iShares MBS ETF
MBB
|
+$6.16M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.48M |
| 4 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$3.47M |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$3.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.89M |
| 2 |
Zebra Technologies
ZBRA
|
+$2.75M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.21M |
| 4 |
Microsoft
MSFT
|
+$2.13M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$1.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.02% |
| 2 | Financials | 11.43% |
| 3 | Healthcare | 10.67% |
| 4 | Industrials | 8.85% |
| 5 | Consumer Discretionary | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
ARK Genomic Revolution ETF
ARKG
$1.51B
| $477K | 0.02% |
15,137
-21,885
| -59% | -$765K |
|
|
SEM
427
DELISTED
Select Medical
SEM
| $476K | 0.02% |
37,410
-1,414
| -4% | -$18.1K |
|
428
Titan Machinery
TITN
$466M
| $475K | 0.02% |
21,186
-1,948
| -8% | -$48.6K |
|
429
Best Buy
BBY
$18B
| $474K | 0.02% |
7,280
-1,286
| -15% | -$107K |
|
430
Ericsson
ERIC
$30.7B
| $473K | 0.02% |
63,865
-3,822
| -6% | -$31.2K |
|
|
SPTN
431
DELISTED
SpartanNash
SPTN
| $465K | 0.02% |
15,442
+76
| +0.5% | +$2.52K |
|
432
Visteon
VC
$2.77B
| $465K | 0.02% |
4,487
| – | – |
|
433
Biogen
BIIB
$29.9B
| $462K | 0.02% |
2,263
+10
| +0.4% | +$2.04K |
|
434
AstraZeneca
AZN
$263B
| $459K | 0.02% |
3,475
+33
| +1% | +$4.33K |
|
435
HCA Healthcare
HCA
$84.8B
| $457K | 0.02% |
2,717
+268
| +11% | +$57.6K |
|
436
Marvell Technology
MRVL
$174B
| $456K | 0.02% |
10,466
+834
| +9% | +$47.3K |
|
|
DMC
437
Del Monte Corp
DMC
$1.35B
| $455K | 0.02% |
15,405
| – | – |
|
438
Vishay Intertechnology
VSH
$5.86B
| $455K | 0.02% |
25,540
-3
| -0% | -$57 |
|
439
Dominion Energy
D
$62.5B
| $454K | 0.02% |
5,693
-544
| -9% | -$44.9K |
|
440
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
| $454K | 0.02% |
4,818
| – | – |
|
441
Winnebago Industries
WGO
$870M
| $454K | 0.02% |
9,365
| – | – |
|
442
RLI Corp
RLI
$5.68B
| $453K | 0.02% |
7,768
-360
| -4% | -$20.6K |
|
443
Stewart Information Services
STC
$2.05B
| $443K | 0.02% |
8,914
-5
| -0.1% | -$268 |
|
444
SS&C Technologies
SSNC
$17.8B
| $438K | 0.02% |
7,549
-533
| -7% | -$34.3K |
|
445
Hamilton Lane
HLNE
$3.63B
| $436K | 0.02% |
6,491
-386
| -6% | -$26.6K |
|
446
Marcus & Millichap
MMI
$1.15B
| $433K | 0.02% |
11,702
+50
| +0.4% | +$2.17K |
|
447
Ameriprise Financial
AMP
$46.8B
| $425K | 0.02% |
1,790
-12
| -0.7% | -$3.21K |
|
448
Ormat Technologies
ORA
$6.11B
| $424K | 0.02% |
5,406
-219
| -4% | -$17.3K |
|
449
Amphenol
APH
$188B
| $423K | 0.02% |
13,140
-128
| -1% | -$4.45K |
|
|
ACH
450
Accendra Health
ACH
$240M
| $423K | 0.02% |
13,464
-5
| -0% | -$181 |
|
Similar funds
XT
AAM
RWM
SAM
FWI
PP
VH
KIM
Hancock Whitney's Q2 2022 Portfolio in Review
As of Q2 2022, Hancock Whitney held 698 positions worth $2.5B, down 15% from $2.94B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Hancock Whitney's Q2 2022 filing shows 16 new, 159 increased, 431 reduced and 66 closed positions. Its largest new stake was Corpay: 6,768 shares worth $1.42M. The largest sale was Apple, an estimated $2.89M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- Hancock Whitney's largest Q2 2022 buy was Corpay: 6,768 shares worth $1.42M.
- Hancock Whitney added most to SPDR Gold Trust in Q2 2022, an estimated $26.6M increase.
- Hancock Whitney's biggest Q2 2022 reduction was Apple, cutting an estimated $2.89M.
- Hancock Whitney fully exited Primerica in Q2 2022, selling an estimated $1.27M.
- Hancock Whitney's ten largest holdings make up 27% of its $2.5B portfolio in Q2 2022.
- Hancock Whitney opened 16 new positions and closed 66 in Q2 2022.
- Hancock Whitney's portfolio value fell 15% quarter-over-quarter to $2.5B.
Based on Hancock Whitney's 13F filing for Q2 2022, filed 8 Aug 2022.